Hemodiafiltration with online regeneration of the ultrafiltrate.
The concept of regeneration of dialysis fluids and of ultrafiltrate in particular has been recently revisited. Hemodiafiltration with online regeneration of the ultrafiltrate allows the concomitant infusion of sodium, calcium, and bicarbonate. Here, we studied the adsorptive characteristics of an integrated two-step sorbent system relative to different solutes present in the ultrafiltrate: sodium, calcium, phosphate, bicarbonate, uric acid, creatinine, and beta2-microglobulin. In vitro studies were performed in order to differentiate the relative roles for each sorbent (mineral-activated charcoal or hydrophobic resin) in adsorbing a given solute. Ex vivo studies were performed in order to evaluate the presence of cytokines (interleukin-1 beta and tumor necrosis factor-alpha), of cytokine (interleukin-1 beta and tumor necrosis factor-alpha)-inducing activities, and of the cytokine release in response to exogenous bacterial lipopolysaccharide by normal whole blood incubated with ultrafiltrate samples obtained at 15, 120, and 240 minutes after the start of treatment. The results of the present studies show the presence of immunomodulatory substances in the ultrafiltrate and the significant (P < 0.01) increase in the lipopolysaccharide-induced release of both interleukin-1 beta and tumor necrosis factor-alpha. The biological relevance of the ultrafiltrate and the possible relevance of the online, endogenous reinfusion are discussed.
Marinez de Francisco
A L
AL
Nephrology Department, Hospital Universitario Valdecilla, Santander, Spain.
Ghezzi
P M
PM
Brendolan
A
A
Fiorini
F
F
La Greca
G
G
Ronco
C
C
Arias
M
M
Gervasio
R
R
Tetta
C
C
D000327:Adsorption; D002606:Charcoal; D002851:Chromatography, High Pressure Liquid; D017583:Hemodiafiltration / Q000295:instrumentation* / Q000379:methods*; D006801:Humans; D007375:Interleukin-1 / Q000493:pharmacokinetics*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha / Q000493:pharmacokinetics*; D014511:Uremia / Q000628:therapy
D007375:Interleukin-1; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D002606:Charcoal